NYU Langone Health announced on May 4 that it has secured a nearly $70 million, seven-year renewal grant from the National Institutes of Health to support its Clinical and Translational Science Institute. The award is the highest level of funding available nationally under the NIH’s Clinical and Translational Science Awards Program.
The funding aims to help NYU Langone move scientific discoveries into patient care more quickly. The Clinical and Translational Science Institute provides resources such as biostatistics support, patient data infrastructure, clinical trial networks, and career development programs for scientists and clinicians. These services are designed to make research more accessible across departments.
“This award positions NYU Langone at the forefront of translational science,” said Miriam A. Bredella, MD, MBA, director of the CTSI. “Through the CTSI, we are building the infrastructure to move discoveries into real-world patient care faster and at scale.”
Since its founding in 2009, the institute has supported nearly 5,000 requests—more than half led by early-career investigators—and contributed to over 1,500 grants and peer-reviewed publications. With this new grant period, NYU Langone plans to expand efforts in community-engaged research, broaden access to health informatics tools, train researchers at all levels, foster collaborations regionally and nationally, and speed up clinical trial processes.
“Translational research is central to our mission at NYU Langone,” said Dafna Bar-Sagi, PhD. “The CTSI is a critical institutional engine that allows us to turn scientific discovery into better care for patients across New York City and beyond. This award reflects both the strength of our research enterprise and our commitment to ensuring that innovation reaches patients quickly, equitably, and at scale.”
NYU Langone’s broad network—including Family Health Centers; NYC Health + Hospitals; all schools within New York University; inpatient locations; outpatient centers in New York area and Florida; tuition-free medical schools in Manhattan and Long Island—positions it as a major center for translational research.
